Lars M. Asmis

1.6k total citations
51 papers, 1.2k citations indexed

About

Lars M. Asmis is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lars M. Asmis has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Internal Medicine and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lars M. Asmis's work include Venous Thromboembolism Diagnosis and Management (15 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Lars M. Asmis is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). Lars M. Asmis collaborates with scholars based in Switzerland, United States and Germany. Lars M. Asmis's co-authors include Burkhardt Seifert, Oliver M. Theusinger, Donat R. Spahn, Lorenzo Alberio, Dimitrios A. Tsakiris, Walter A. Wuillemin, Anne Angelillo‐Scherrer, Wolfgang Korte, Hans Stricker and Reto Asmis and has published in prestigious journals such as New England Journal of Medicine, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Lars M. Asmis

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars M. Asmis Switzerland 21 296 282 254 233 227 51 1.2k
Jari Petäjä Finland 19 172 0.6× 201 0.7× 107 0.4× 323 1.4× 351 1.5× 60 1.0k
Kiran Parmar United Kingdom 18 154 0.5× 133 0.5× 144 0.6× 103 0.4× 305 1.3× 40 1.4k
Ingvild Birschmann Germany 23 323 1.1× 623 2.2× 64 0.3× 313 1.3× 400 1.8× 70 1.7k
G. Freyburger France 16 243 0.8× 174 0.6× 169 0.7× 211 0.9× 187 0.8× 34 881
Martti Syrjälä Finland 19 78 0.3× 224 0.8× 96 0.4× 202 0.9× 358 1.6× 49 1.2k
J H Joist United States 23 252 0.9× 518 1.8× 145 0.6× 554 2.4× 431 1.9× 54 1.7k
Peter Kubisz Slovakia 22 369 1.2× 556 2.0× 93 0.4× 250 1.1× 588 2.6× 163 1.5k
Ján Staško Slovakia 20 339 1.1× 488 1.7× 103 0.4× 199 0.9× 471 2.1× 134 1.3k
Thomas Slaughter United States 20 216 0.7× 287 1.0× 260 1.0× 508 2.2× 320 1.4× 49 1.3k
Thomas Vukovich Austria 21 254 0.9× 356 1.3× 43 0.2× 440 1.9× 257 1.1× 32 1.2k

Countries citing papers authored by Lars M. Asmis

Since Specialization
Citations

This map shows the geographic impact of Lars M. Asmis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars M. Asmis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars M. Asmis more than expected).

Fields of papers citing papers by Lars M. Asmis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars M. Asmis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars M. Asmis. The network helps show where Lars M. Asmis may publish in the future.

Co-authorship network of co-authors of Lars M. Asmis

This figure shows the co-authorship network connecting the top 25 collaborators of Lars M. Asmis. A scholar is included among the top collaborators of Lars M. Asmis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars M. Asmis. Lars M. Asmis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seifert, Burkhardt, Lars M. Asmis, Patrick Imesch, et al.. (2023). Judging Urgency in 343 Ectopic Pregnancies Prior to Surgery – The Importance of Transvaginal Sonographic Diagnosis of Intraabdominal Free Blood. Ultraschall in der Medizin - European Journal of Ultrasound. 44(6). 614–622.
2.
Studt, Jan–Dirk, Lorenzo Alberio, Pierre Fontana, et al.. (2022). Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study. Frontiers in Cardiovascular Medicine. 9. 817826–817826. 10 indexed citations
3.
Kockmann, Tobias, et al.. (2021). The Angiostrongylus vasorum Excretory/Secretory and Surface Proteome Contains Putative Modulators of the Host Coagulation. Frontiers in Cellular and Infection Microbiology. 11. 753320–753320. 14 indexed citations
4.
Casini, Alessandro, Lorenzo Alberio, Anne Angelillo‐Scherrer, et al.. (2020). Thromboprophylaxis and laboratory monitoring for in-hospital patients with Covid-19 - a Swiss consensus statement by the Working Party Hemostasis. Swiss Medical Weekly. 150. w20247–w20247. 69 indexed citations
5.
Fontana, Pierre, Lorenzo Alberio, Manuela Albisetti, et al.. (2020). Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab. Swiss Medical Weekly. 150(5153). w20422–w20422. 14 indexed citations
6.
Cushing, Melissa M., Lars M. Asmis, Rebecca M. Harris, et al.. (2019). Efficacy of a new pathogen‐reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro. Transfusion. 59(5). 1818–1826. 11 indexed citations
7.
Asmis, Lars M., Lorenzo Alberio, Anne Angelillo‐Scherrer, et al.. (2011). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests. Thrombosis Research. 129(4). 492–498. 117 indexed citations
8.
Valsami, Serena, et al.. (2010). Immunomodulatory drugs increase endothelial tissue factor expression in vitro. Thrombosis Research. 127(3). 264–271. 14 indexed citations
9.
Nendaz, Mathieu, Pierre Chopard, Christian Lovis, et al.. (2010). Adequacy of venous thromboprophylaxis in acutely ill medical patients (IMPART): multisite comparison of different clinical decision support systems. Journal of Thrombosis and Haemostasis. 8(6). 1230–1234. 31 indexed citations
10.
Stover, John F., Reto Stocker, Lars M. Asmis, et al.. (2010). Two different hematocrit detection methods: Different methods, different results?. BMC Research Notes. 3(1). 65–65. 7 indexed citations
11.
Asmis, Lars M., Felix C. Tanner, Isabella Sudano, Thomas F. Lüscher, & Giovanni G. Camici. (2009). DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents?. Biochemical and Biophysical Research Communications. 391(4). 1629–1633. 29 indexed citations
12.
Theusinger, Oliver M., et al.. (2009). Rotation thromboelastometry (ROTEM®) stability and reproducibility over time☆. European Journal of Cardio-Thoracic Surgery. 37(3). 677–683. 118 indexed citations
13.
Kuhn, M, et al.. (2009). Particulate matter inhalation during hay storing activity induces systemic inflammation and platelet aggregation. European Journal of Applied Physiology. 105(5). 771–778. 27 indexed citations
14.
Plantinga, Laura, Nancy E. Fink, Thomas S. Kickler, et al.. (2008). Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and Haemostasis. 100(9). 498–504. 29 indexed citations
15.
Stämpfli, Simon F., Lars M. Asmis, & Felix C. Tanner. (2008). Wirkungsweise alter und neuer Antikoagulanzien. Herz. 33(1). 4–12.
16.
Schmidt, Dörthe, Lars M. Asmis, Bernhard Odermatt, et al.. (2006). Engineered Living Blood Vessels: Functional Endothelia Generated From Human Umbilical Cord-Derived Progenitors. The Annals of Thoracic Surgery. 82(4). 1465–1471. 48 indexed citations
17.
Wang, Yanmei, Mu Qiao, John J. Mieyal, Lars M. Asmis, & Reto Asmis. (2006). Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: Role of glutathione reductase and glutaredoxin. Free Radical Biology and Medicine. 41(5). 775–785. 59 indexed citations
18.
Asmis, Lars M. & Christophe Girardet. (2002). Systemic Mast-Cell Disease (Mastocytosis). New England Journal of Medicine. 346(3). 174–174. 3 indexed citations
19.
Kimura, Edna Teruko, Peter Kopp, Lars M. Asmis, et al.. (1999). Expression of Transforming Growth Factor β 1 , β 2 , and β 3 in Multinodular Goiters and Differentiated Thyroid Carcinomas: A Comparative Study. Thyroid. 9(2). 119–125. 41 indexed citations
20.
Asmis, Lars M., et al.. (1995). Epidermal growth factor stimulates cell proliferation and inhibits iodide uptake of FRTL-5 cells in vitro. Journal of Endocrinology. 145(3). 513–520. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jari Petäjä Breakdown of academic impact, for papers by Kiran Parmar Breakdown of academic impact, for papers by Ingvild Birschmann Breakdown of academic impact, for papers by G. Freyburger Breakdown of academic impact, for papers by Martti Syrjälä Breakdown of academic impact, for papers by J H Joist Breakdown of academic impact, for papers by Peter Kubisz Breakdown of academic impact, for papers by Ján Staško Breakdown of academic impact, for papers by Thomas Slaughter Breakdown of academic impact, for papers by Thomas Vukovich
Rankless by CCL
2026